6. Helmholtz-Zentrum Dresden-Rossendorf Ev

go to website

Michael Bachmann:
go to group

Anja Feldmann:
go to page

Claudia Arndt:
go to page

Expertise, Role and Activity

The Institute of Radiopharmaceutical Cancer Research at HZDR is focused on research and development towards radiolabelled compounds and immunotherapeutics including antibody derivatives and cellular immunotherapies based on chimeric antigen receptor (CARs) for the therapy and diagnosis of tumors  and has a key role in WP5. HZDR has a critical role in the generation of B-specific immunotherapies and has been in consortium with other partners from the consortium like Prof. Karen Vanhoorelbeke and Dr. Nick Geukens from KUL.

All the Consortium